Sexual disorders in men suffering from hypertension and their possible correction
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The investigation of the effectiveness of the combined therapy with sildenafil, sildenafil and arginin, sildenafil, arginin and LNP therapy was carried out in 120 hypertensive patients with erectile dysfunction.
The patients were divided into several groups. Group I (25 patients) got therapy with inhibitors of phosphodiasterase of 5 type (sildenafil) on demand; Group II (25 patients) got sildenafil in a dose of 50 mg every other day; Group III (25 patients) – sildenafil in a dose of 50 mg every other day + arginin; Group IV (25 patients) – sildenafil +arginin+LNP therapy; Group V (20 patients) was a group of comparison.
The final estimation of the effectiveness of complex therapy in a month showed good and perfect results in 96,0% of patients of Group IV and 84,0% of patients of Group III. Poorer results were revealed in patients of Group I and Group II. In Group V indexes didn’t change but in 2 patients (10,0%) results worsened.
On the basis of carried out investigation it was established that arginin and LNP therapy improved treatment.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Alyaiev Yu.G. Opyt dlytelnogo I nepreryvnogo lechenia vardenafilom tyazholykh form narushenia erektsyii / Yu.G. Alyaiev, A.Z. Vinarov, N.D. Akhvlediani // Urologia. – 2005. – No 5. – S. 64–66.
Vozianov O.F. Zastosuvania Viargy u likuvani patsientiv z erektylnoyu dysfunktsiyeyu / O.F. Vozianov, I.I. Gorpinchenko, M.I. Zhvavo // Urologia. – 2000. – No 4. – S. 60–66.
Gorpynchenko I.I. Likuvanniya sudynnoyi kopulyatyvnoyi dysfunktsii / I.I. Gorpynchenko, Ya.O. Miroshnykov // Urologia. – 2001. – No 2. – S. 61–64.
Sytenko A.M. Kongres Europeiskogo obshchestva seksualnoyi medytsyny (EOCM) / A.M. Sytechko // Zdorov’ye muzhchyn. – 2006. – No 4. – S. 24–25.
Loran O.B. Viagra (sildenafil citrate) v lechenyii bol’nykh s erektylnoyi dysfunktsyei / O.B. Loran, Yu.G. Alyaiev, P.A. Shepl’ov // Urologia. – 2000. – No 1. – S. 30–33.
Wei M. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction / M. Wei, C. Macera, D. Davis [et al] // Am J. Epidemiol. – 2004. – No 3. – Р. 930-937.
Klein R. Prevalence of self-reported erectile dysfunction in people with long-term IDDM / R. Klein, B. Klein, R. Lee [et al] // J. Diabetes Care – 2006.No19Р. 135-141.
Kloner R. Erectile dysfunction and atherosclerosis / R. Kloner, M. Speakman // Curr Athewscler Rep.2002.No4.Р. 397-401.
